Dissection of Level III Axillary Lymph Nodes in Breast Cancer. 2021

Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
Breast Surgery Department, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou City, Zhejiang Province, People's Republic of China.

Axillary lymph node dissection is an indispensable step in modified radical mastectomy for breast cancer. It is the most reliable method and the golden standard to determine the status of axillary lymph nodes. It is also of great importance to evaluate the prognosis and develop treatment plans for breast cancer patients. Axillary lymph node dissection can be anatomically divided into levels I, II, and III. Level I and Level II axillary lymph dissection is the standard clinical treatment of axillary lymph nodes positive breast cancer, whereas level III axillary lymph node dissection has been controversial. Level III axillary lymph node metastasis is one of the important factors that can easily cause distant metastasis and recurrence. It is also an important index to estimate the prognosis of breast cancer patients. To facilitate the decision of whether or not to perform level III lymph node dissection, we reviewed the indications, complications, and surgical procedures of level III lymph node dissection.

UI MeSH Term Description Entries

Related Publications

Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
November 2019, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine,
Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
December 2013, Breast (Edinburgh, Scotland),
Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
July 1992, Lancet (London, England),
Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
July 1992, Lancet (London, England),
Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
July 1992, Lancet (London, England),
Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
July 1992, Lancet (London, England),
Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
July 1992, Lancet (London, England),
Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
January 1978, Surgery annual,
Jiejie Hu, and Xianghou Xia, and Hongjian Yang, and Yang Yu
March 2014, World journal of surgical oncology,
Copied contents to your clipboard!